Focusing on acquisitions
From 2000 onwards, HARTMANN focused heavily on acquisitions. 2000 saw the acquisition of Karl Otto Braun GmbH & Co. KG – a specialist in bandages and wovens for venology and lymphology, as well as for sports medicine, orthopaedics and wound care. In 2001, 80 percent of Kneipp was acquired before HARTMANN wholly absorbed the specialist for body care and bath products, pharmaceuticals and dietary supplements in 2008. Sanimed has been another subsidiary of HARTMANN since 2001, as a company whose manufacturing portfolio includes products for ambulatory patient care. In 2009, BODE Chemie GmbH with its Sterillium brand also became part of the Group. This acquisition has enabled HARTMANN to provide a first-hand offering of system solutions for protecting against infections.
Today, PAUL HARTMANN AG is represented in more than 35 countries on all continents, with over 10,700 employees. In 2016, the company generated sales revenue of almost two billion Euros. From its beginnings, the Group has been a driving force in advancing the health care industry worldwide. From the start, HARTMANN’s core distinguishable strength has been its proximity and partnerships with customers, the professional nursing field and patients. Together we continue to develop solutions that sustainably enhance the quality of medical treatment and create measurable added value for healthcare workers and patients alike – on the one hand through the easier applicability of products and systems, but also through their positive economic effect. PAUL HARTMANN AG and its employees, who form the basis of its success, will continue pursuing this path into the future.